ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,264Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 3647

$1.12M Total Retail Price of All Prescriptions

Rank: 169 out of 3647

1,430 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,430 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 1,430 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 26,691 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 2,111 1,807 1 1
LEVOTHYROXINE SODIUM 1,174 1,051 2 5
OMEPRAZOLE 948 801 3 3
ENALAPRIL MALEATE 934 827 4 35
METFORMIN HCL 929 788 5 6
AMLODIPINE BESYLATE 851 720 6 2
FUROSEMIDE 705 604 7 8
ALENDRONATE SODIUM 679 565 8 23
ATENOLOL 618 543 9 10
METOPROLOL TARTRATE 573 464 10 7
LISINOPRIL 567 457 11 4
LOSARTAN POTASSIUM 561 497 12 11
ISOSORBIDE MONONITRATE ER 503 460 13 56
ALPRAZOLAM 448 371 14 31
HYDROCODONE-ACETAMINOPHEN 447 298 S3 15 12
ZOLPIDEM TARTRATE 430 372 16 14
PRAVASTATIN SODIUM 404 323 17 16
TRIAMTERENE-HCTZ 399 355 18 58
WARFARIN SODIUM 396 365 19 15
CALCITRIOL 386 274 20 265
HYDROCHLOROTHIAZIDE 352 302 21 9
LOSARTAN-HYDROCHLOROTHIAZIDE 352 316 21 48
GLIPIZIDE 344 300 23 41
TRAMADOL HCL 328 254 24 22
TAMSULOSIN HCL 322 305 25 28
MELOXICAM 310 289 26 33
HYDRALAZINE HCL 293 272 27 81
GEMFIBROZIL 288 220 28 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 287 196 29 36
ATORVASTATIN CALCIUM 283 272 30 13
CITALOPRAM HBR 279 256 31 25
BACLOFEN 275 189 32 97
POTASSIUM CHLORIDE 274 247 33 24
KLOR-CON 10 272 218 34 106
CLOPIDOGREL 270 252 35 26
VERAPAMIL ER 266 221 36 99
DOXAZOSIN MESYLATE 246 224 37 57
GLYBURIDE 242 211 R 38 54
LOVASTATIN 240 224 39 21
FLUTICASONE PROPIONATE 237 190 40 32
DIGOXIN 210 208 41 51
DILTIAZEM ER 210 175 41 167
RANITIDINE HCL 208 164 43 29
NIFEDIPINE ER 207 163 44 67
DICLOFENAC SODIUM 201 155 45 86
AZITHROMYCIN 201 149 45 34
CIPROFLOXACIN HCL 197 164 47 53
CARVEDILOL 196 164 48 20
PLAVIX 186 177 49 39
TEMAZEPAM 180 162 50 47
CLONIDINE HCL 172 116 51 46
METOPROLOL SUCCINATE 162 139 52 18
SPIRONOLACTONE 155 147 53 77
GABAPENTIN 154 115 54 17
ALLOPURINOL 147 143 55 37
JANTOVEN 146 146 56 140
DONEPEZIL HCL 144 135 57 30
NAPROXEN 144 98 57 70
OXYCODONE HCL-ACETAMINOPHEN 141 75 S2 59 104
SULFAMETHOXAZOLE-TRIMETHOPRIM 135 104 60 110
METHYLPREDNISOLONE 130 107 61 78
PREDNISONE 130 116 61 43
OXYCODONE-ACETAMINOPHEN 129 100 S2 63 91
INSULIN SYRINGE 127 97 64 76
FINASTERIDE 124 124 65 66
LANTUS 119 79 66 59
PROAIR HFA 118 72 67 62
CRESTOR 116 113 68 19
MINOXIDIL 114 90 69 442
IBUPROFEN 114 67 69 55
FENOFIBRATE 112 95 71 50
LEVOXYL 112 108 71 125
LORAZEPAM 107 95 73 73
OXYCODONE HCL 106 60 S2 74 75
CARTIA XT 105 99 75 242
OXYBUTYNIN CHLORIDE 104 98 76 107
SERTRALINE HCL 102 67 77 27
TRIAMTERENE-HYDROCHLOROTHIAZID 97 97 78 223
TERAZOSIN HCL 96 96 79 103
MECLIZINE HCL 93 77 80 85
DIOVAN 90 68 81 40
LANTUS SOLOSTAR 78 71 82 124
DIAZEPAM 78 78 82 214
FAMOTIDINE 77 74 84 61
NEXIUM 77 60 84 44
VIAGRA 76 61 86 69
GLIMEPIRIDE 75 58 87 45
GENERLAC 73 65 88 278
RISPERIDONE 73 28 88 83
AMOXICILLIN 73 52 88 133
RAMIPRIL 72 69 91 101
ADVAIR DISKUS 72 61 91 52
FLUOXETINE HCL 72 47 91 68
AMOX TR-POTASSIUM CLAVULANATE 70 59 94 118
PANTOPRAZOLE SODIUM 69 66 95 38
PAROXETINE HCL 66 48 96 60
GLIPIZIDE ER 65 56 97 112
NIFEDICAL XL 65 65 97 221
DILTIAZEM HCL 64 64 99 253
ENDOCET 63 37 S2 100 269
METOLAZONE 62 39 101 251
DILTIAZEM 24HR CD 62 62 101 155
BYSTOLIC 61 48 103 158
PHENYTOIN SODIUM EXTENDED 60 48 104 199
CYCLOBENZAPRINE HCL 60 15 R 104 98
CARISOPRODOL 60 11 R 104 115
HUMULIN 70-30 60 51 104 192
NOVOLIN 70-30 59 33 108 130
MEGESTROL ACETATE 59 55 R 108 138
NOVOLIN N 57 55 110 320
DIOVAN HCT 57 35 110 80
DILTIAZEM 24HR ER 56 56 112 164
PRAMIPEXOLE DIHYDROCHLORIDE 55 54 113 307
VENTOLIN HFA 54 43 114 88
METHADONE HCL 54 27 S2 114 174
CILOSTAZOL 54 52 114 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.